The Latest Breaking News from Joseph Pantginis

Critical Insights From Pharming Analyst Ratings: What You Need To Know

6 analysts have expressed a variety of opinions on Pharming (NASDAQ:PHAR) over the past quarter, offering a diverse set of opinions from bullish to bearish.

Benzinga · Dec 9, 2024

A Glimpse Into The Expert Outlook On XOMA Royalty Through 4 Analysts

XOMA Royalty (NASDAQ:XOMA) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

Benzinga · Dec 3, 2024